Weekly Supplement: Week Ending March 1, 2024

To view the issue, please CLICK HERE.

In this Weekly Supplement, we provide the second part of our coverage of a panel session at the 2024 CASSS WCBP Conference, which brought together regulators from five different regulatory agencies and WHO to discuss “transforming global regulatory CMC practices in an age of regulatory innovation.”

The first part focused on the summary remarks provided by each of the panelists on the engagement of their respective agencies/organization with the evolving CMC practices and international collaborative initiatives.

Part II reviews the Q&A discussion that followed at the session in which the panelists had a chance to dig deeper into some of the key issues and developments in the international collaboration arena.

Our Weekly Supplements include a summary listing of the “News in Brief,” drug GMP warning letters and recalls, and EMA non-compliance reports (NCRs) that have been posted on IPQ’s website during the week. Subscribers can then click through to the full posting.

Also provided, where applicable, are links to the parts of in-depth stories and Monthly Updates that have been released during the week.

Appended to the issue is a chronological listing of the headlines of the in-depth stories that IPQ has released since 2020. Readers of the Weekly Supplement are invited to click through to those that are of particular relevance to the regulatory presentation, news briefs, or compliance developments provided in the issue. Those of especially high relevance to the featured regulator story are indicated with a red star.